FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2017/12/010793 [Registered on: 07/12/2017] Trial Registered Prospectively
Last Modified On: 01/12/2017
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Role of Jivantyadi churna in the management of Tamaka Shwasa 
Scientific Title of Study   Management of Tamaka Shwasa (Bronchial Asthma) in Children with Jivantyadi Churna and Shwasahara Dashemani Churna - An Open Labelled, Randomized, Comparative Clinical Trial 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Chuman lal Bhaskar 
Designation  MD Second year 
Affiliation  Ipgt and ra Jamnagar 
Address  OPD No 24 Kaumarbhritya department IPGT and ra Gujarat ayurved University Jamnagar India
OPD No 24 Kaumarbhritya department IPGT and ra Gujarat ayurved University Jamnagar India
Jamnagar
GUJARAT
361008
India 
Phone  9512843829  
Fax    
Email  chumanlalbhaskar@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof K S Patel 
Designation  Professor and HOD Kaumarbhritya department ipgt and ra Jamnagar 
Affiliation  IPGT AND RA JAMNAGAR 
Address  Kaumsrbhritya department ipgt and Ra Gujarat ayurved university Jamnagar 361008 India
Kaumsrbhritya department ipgt and Ra Gujarat ayurved university Jamnagar 361008 India
Jamnagar
GUJARAT
361008
India 
Phone  9427574566  
Fax    
Email  drkspatel2007@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr V K Kori 
Designation  Associate Professor IPGT and RA Gujarat ayurved university 
Affiliation  IPGT AND RA JAMNAGAR 
Address  Kaumarbhritya department ipgt and ra Gujarat ayurved university Jamnagar 361008 India
Kaumarbhritya department ipgt and ra Gujarat ayurved university Jamnagar 361008 India
Jamnagar
GUJARAT
361008
India 
Phone  9374548475  
Fax    
Email  drvkkori@yahoo.co.in  
 
Source of Monetary or Material Support  
Director of IPGT @ RA GAU JAMNAGAR 
 
Primary Sponsor  
Name  Director IPGT and RA GAU JAMNAGAR 
Address  IPGT and RA GAU JAMNAGAR 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Chuman lal Bhaskar  PG Hospital IPGT and RA Jamnagar  PG Hospital Kaumarbhritya Dept OPD IPGT and RA Jamnagar Gujarat Jamnagar GUJARAT
Jamnagar
GUJARAT 
9512843829

chumanlalbhaskar@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Institute For Post Graduate Teaching And Research Ayurveda Gujarat Ayurved University Jamnagar 361008 PGT/7/-A/Ethics/2017-2018/2093  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  Patients having sign and symptoms of bronchial asthma,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  in Group A Jivantyadi Churna referance Astang Hridya Chikitsa sthana Shlok no 4/43-45  18 drugs of Jivantyadi churna named as Jivanti Leptadenia reticulata W & R Nagarmotha Cyperus rotandus Linn. Tulsi Ocimum sanctum Linn. Dalchini Cinnamomnm Cassia (L.) Badi elaichi Amomum Subulatum Roxb. Chhoti elaichi Elettaria Cardamomum Maton. Pushkaramoola Inula racemosa. Hook. F Chanda Angelica Archangeica Linn Bhumyamalaki Phyllanthus Fraternus L. Agaru Acquilaria agallocha Roxb. Bharangi Clerodendrum Serratum Linn. Shunthi Zingiber Officinale Roscope. Shugandhabala Pavonia odorata Willd. Karkatshringi Pistacia integerrima Stew. Kachura Curcuma Zedoaria Rosc. Pippalimoola Piper longum Linn. Nagakeshar Ochrocarpu Longifolius Benth & Hook.F. Choraka Angelica glauca Edgew.  
Comparator Agent  In Group B Shwasahara Dashemani Churna reference caraka samhita sutra sthan shlok no 4/37  10 content in Shwasahara Dashemani churna namely Shati Hedychium spicatum Pushkara mool Inula racemosa Amlavetasa Rheum emodi Ela Elettaria cardamomum Hingu Ferula narthex Agaru Acquilaria agallocha Sursa Ocimum sanctum Tamalaki Phylenthus niruri Jivanti Laptidinia reticulate Chanda Angelica glauca 
 
Inclusion Criteria  
Age From  2.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  1 Patients of 2 – 12 years of age group of either sex
2 Diagnosed cases of Tamaka Shwasa (Bronchial Asthma) with at least 2 episodes of asthma symptoms during the previous year
3 Patients on other drug therapy will be included only after completion of wash out period of 2 weeks
4 Mild persistent asthmatic patients
5 Patients on other drug therapy will be included only after completion 
 
ExclusionCriteria 
Details  1 Children of age below 2 years and above 12 years
2 Patients with status asthmatics Evidence of active Concomitant Pulmonary Diseases other than
asthma
3 Evidence of requirement of intubations for asthma or had been hospitalized for asthma within one month before Unresolved Sinus Disease or an unresolved upper or lower respiratory tract infection within 4 weeks
4 Concomitant severe de-compensated systemic disease (cardiovascular renal hepatic endocrine hematological neurological immunological). 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
relieve in the sign and symptom of shwasa roga
or Bronchial asthma 
8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
To prevent the recurrence of attack of
breathlessness
To increase the immunity against allergens 
8 weeks 
 
Target Sample Size   Total Sample Size="30"
Sample Size from India="30" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   14/02/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   No any related publication 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   Present clinical trial is randomised clinical trail on Tamaka Shwsa (Bronchial Asthma) in children of
either sex between 2 to 12 years of age. Study will evaluate the role of jivantyadi Churna and Shwasahara
Dashemani churna. Intervational drug isjivantyadi Churna  while comparator agent is Shwasahara Dashemani churna.
Study is going to be conducted with primary aim to relieve the symptom of childhood asthma
Till date 30 patients will be registered in clinical trial
As trial as in progress final conclusion or remarks can be drawn only after the completion of clinical
trial
 
Close